Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rolf Kalff
Long-Term Analysis of the NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Readmission to a Surgical Intensive Care Unit: Incidence, Outcome and Risk Factors
Critical Care
Critical Care
Intensive Care Medicine
Related publications
Phase II Trial of Pre-Irradiation and Concurrent Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendrogliomas and Mixed Anaplastic Oligoastrocytomas: Long Term Results of RTOG BR0131
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
Outcomes for Anaplastic Glioma Treated With Radiation Therapy With or Without Concurrent Temozolomide
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Accelerated Hyperfractionated Radiochemotherapy With Temozolomide Is Equivalent to Normofractionated Radiochemotherapy in a Retrospective Analysis of Patients With Glioblastoma
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Response of Leptomeningeal Dissemination of Anaplastic Glioma to Temozolomide: Experience of Two Cases
Brain Tumor Research and Treatment
Long-Term Follow-Up of the Randomized (BIOMArCS-2) Glucose Trial
Circulation
Cardiovascular Medicine
Physiology
Cardiology
A Phase II Randomized Study of Concurrent vs Sequential Letrozole With Adjuvant Hypo-Fractionated Radiotherapy: Long Term Toxicity and Survival Outcomes
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI‐Bevacizumab Versus FOLFOX‐Bevacizumab for Metastatic Colorectal Cancer (STEAM)
Oncologist
Cancer Research
Medicine
Oncology
Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial
Headache
Neurology
Randomized Trial of the Combination of Lomeguatrib and Temozolomide Compared With Temozolomide Alone in Chemotherapy Naive Patients With Metastatic Cutaneous Melanoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology